Artificial pancreas feasible in home trials

The first long-term trial of a closed loop insulin delivery system has shown it can be safely used unsupervised by patients overnight at home for periods of several weeks.

In results released at the American Diabetes Association conference this week, UK researchers showed that the closed loop ‘artificial pancreas’ was feasible for home use by patients with type 1 diabetes, in whom it improved glucose control.

The system monitors glucose levels and uses a software algorithm to adjust

Latest

Trending